Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition): Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, specific BET, DUB and other inhibitors), Therapeutic Areas (Neurological Disorders, Oncological Disorders and Others), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and Rest of the World), 2021-2030

  • Lowest Price Guaranteed From USD 5,899

  • Published
    March 2021

  • Pages

  • View Count

Request Customization
Please select a suitable option for customization in the report

NOTE! All customization requests will be dealt with on a case by case basis subject to availability of the information


USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases